Stacie Stapleton

843 total citations
27 papers, 313 citations indexed

About

Stacie Stapleton is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Stacie Stapleton has authored 27 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Stacie Stapleton's work include Glioma Diagnosis and Treatment (10 papers), Cancer-related molecular mechanisms research (7 papers) and Neuroblastoma Research and Treatments (5 papers). Stacie Stapleton is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Cancer-related molecular mechanisms research (7 papers) and Neuroblastoma Research and Treatments (5 papers). Stacie Stapleton collaborates with scholars based in United States, Canada and France. Stacie Stapleton's co-authors include Susan M. Blaney, George I. Jallo, Ranjan J. Perera, Charles G. Eberhart, Denise M. Adams, Ernest K. Amankwah, Patrick A. Thompson, Chetan Bettegowda, Gary Stapleton and Rabi Murad and has published in prestigious journals such as Clinical Cancer Research, Cell Reports and Neuro-Oncology.

In The Last Decade

Stacie Stapleton

26 papers receiving 309 citations

Peers

Stacie Stapleton
Stacie Stapleton
Citations per year, relative to Stacie Stapleton Stacie Stapleton (= 1×) peers Mersiha Hadziahmetovic

Countries citing papers authored by Stacie Stapleton

Since Specialization
Citations

This map shows the geographic impact of Stacie Stapleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacie Stapleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacie Stapleton more than expected).

Fields of papers citing papers by Stacie Stapleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacie Stapleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacie Stapleton. The network helps show where Stacie Stapleton may publish in the future.

Co-authorship network of co-authors of Stacie Stapleton

This figure shows the co-authorship network connecting the top 25 collaborators of Stacie Stapleton. A scholar is included among the top collaborators of Stacie Stapleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacie Stapleton. Stacie Stapleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phan, Philippe, Stacie Stapleton, Gregory J. Riggins, et al.. (2025). Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors. Neuro-Oncology Practice. 12(6). 1092–1098. 1 indexed citations
2.
Katsushima, Keisuke, Kandarp Joshi, Mona Batish, et al.. (2024). A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastoma. Cell Reports. 43(3). 113938–113938. 5 indexed citations
3.
Joshi, Kandarp, Keisuke Katsushima, Olivier Saulnier, et al.. (2024). Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis. Acta Neuropathologica Communications. 12(1). 138–138. 3 indexed citations
4.
Cohen, Kenneth J., Dolly Aguilera, Robert C. Castellino, et al.. (2023). A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma. Clinical Cancer Research. 29(24). 5031–5037. 9 indexed citations
5.
Katsushima, Keisuke, Rudramani Pokhrel, Iqbal Mahmud, et al.. (2023). The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas. Acta Neuropathologica Communications. 11(1). 38–38. 4 indexed citations
6.
Lee, Bongyong, Keisuke Katsushima, Rudramani Pokhrel, et al.. (2022). The long non-coding RNA SPRIGHTLY and its binding partner PTBP1 regulate exon 5 skipping of SMYD3 transcripts in group 4 medulloblastomas. Neuro-Oncology Advances. 4(1). vdac120–vdac120. 6 indexed citations
7.
Bradfield, Scott M., et al.. (2022). A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors. Child s Nervous System. 38(5). 919–928. 3 indexed citations
8.
Katsushima, Keisuke, Bongyong Lee, Cuncong Zhong, et al.. (2020). The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas. Neuro-Oncology. 23(4). 572–585. 26 indexed citations
9.
Katsushima, Keisuke, Piyush Joshi, Stacie Stapleton, et al.. (2020). MBRS-16. MYC REGULATED LONG NONCODING RNA LNC-HLX-2–7 IS A PUTATIVE MOLECULAR MARKER AND A THERAPEUTIC TARGET FOR GROUP 3 MEDULLOBLASTOMAS IN CHILDREN. Neuro-Oncology. 22(Supplement_3). iii401–iii401. 1 indexed citations
10.
Joshi, Piyush, Keisuke Katsushima, Rui Zhou, et al.. (2019). The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma. Neuro-Oncology Advances. 1(1). vdz023–vdz023. 18 indexed citations
11.
Al‐Ibraheemi, Alyaa, et al.. (2019). Clinical characterization and long‐term outcomes in pediatric epithelioid hemangioendothelioma. Pediatric Blood & Cancer. 67(2). e28045–e28045. 13 indexed citations
12.
Wright, Erin, Ernest K. Amankwah, Gerald F. Tuite, et al.. (2018). Incidentally found brain tumors in the pediatric population: a case series and proposed treatment algorithm. Journal of Neuro-Oncology. 141(2). 355–361. 15 indexed citations
13.
Lukas, Claudia, Melissa Crenshaw, Ignacio González-Gómez, et al.. (2018). MBCL-46. COMPOUND HETEROZYGOUS MUTATION OF THE PMS2 GENE IN AN INFANT WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY AND MEDULLOBLASTOMA. Neuro-Oncology. 20(suppl_2). i127–i127. 1 indexed citations
14.
15.
Abdelbaki, Mohamed S, Steven G. Waguespack, Jeremy Jones, et al.. (2017). Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature. Journal of Neuro-Oncology. 135(1). 213–215. 9 indexed citations
16.
Manwaring, Jotham, Amir Ahmadian, Stacie Stapleton, et al.. (2012). Pediatric microcystic meningioma: a clinical, histological, and radiographic case-based review. Child s Nervous System. 29(3). 361–365. 7 indexed citations
17.
Stapleton, Gary, Stacie Stapleton, Nancy A. Ayres, et al.. (2007). Evaluation of Longitudinal Ventricular Function with Tissue Doppler Echocardiography in Children Treated with Anthracyclines. Journal of the American Society of Echocardiography. 20(5). 492–497. 30 indexed citations
18.
Stapleton, Stacie, Patrick A. Thompson, Ching‐Nan Ou, et al.. (2007). Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates. Cancer Chemotherapy and Pharmacology. 61(4). 647–652. 15 indexed citations
19.
Stapleton, Stacie, Joel M. Reid, Patrick A. Thompson, et al.. (2006). Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates. Cancer Chemotherapy and Pharmacology. 59(4). 461–466. 34 indexed citations
20.
Stapleton, Stacie & Susan M. Blaney. (2006). New Agents for Intrathecal Administration. Cancer Investigation. 24(5). 528–534. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026